v3.26.1
Statement of Changes in Stockholders' Equity - 3 months ended Mar. 31, 2026 - USD ($)
Ordinary share
IPO
Ordinary share
Private placement
Ordinary share
Over-Allotment Option
Ordinary share
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private placement
Additional Paid-in Capital
Over-Allotment Option
Additional Paid-in Capital
Accumulated Deficit
IPO
Private placement
Over-Allotment Option
Total
Balance at the beginning at Dec. 31, 2025       $ 575       $ 9,425 $ (21,056)       $ (11,056)
Balance at the beginning (in shares) at Dec. 31, 2025       5,750,000                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Sales of units $ 2,000 $ 28 $ 275   $ 199,998,000 $ 2,749,973 $ 27,499,725     $ 200,000,000 $ 2,750,000 $ 27,500,000  
Number of units issued (in shares) 20,000,000 275,000 2,750,000             20,000,000 275,000 2,750,000  
Sale of 1,000,000 $15 strike warrant in private placement               100,000         100,000
Issuance of underwriter units     $ 3 $ 20     (3) 80         100
Issuance of underwriter units (in shares)     27,500 200,000             227,000    
Forfeiture of founder shares due to partial exercise of over-allotment     $ (6)       $ 6            
Forfeiture of founder shares due to partial exercise of over-allotment (in shares)     (62,500)                    
Reclassification of deferred offering costs               (1,644,947)         (1,644,947)
Class A ordinary shares subject to possible redemptions       $ (2,275)       (227,497,725)         (227,500,000)
Accretion of Class A ordinary shares subject to possible redemption       0       $ (1,214,543) (333,735)       (1,548,269)
Net Income (Loss)       0         1,398,394       1,398,394
Balance at the ending at Mar. 31, 2026       $ 619         $ 1,043,603       $ 1,044,222
Balance at the ending (in shares) at Mar. 31, 2026       28,940,000